Silibinin's Role in Aortic Dissection and Ferroptosis
Author Information
Author(s): Qi Zhen, Wang Qiu-Guo, Huang Meng-Xi, Zeng Yi-Fan, Li Jing-Yu, Duan Zhi-Cheng, Tan Ling, Tang Hao
Primary Institution: Second Xiangya Hospital, Central South University, Changsha, China
Hypothesis
This study aims to elucidate the involvement of ferroptosis in aortic dissection progression and explore ferroptosis inhibition as a potential therapeutic approach for aortic dissection management.
Conclusion
Silibinin effectively mitigates ferroptosis in human aortic smooth muscle cells and offers a promising therapeutic avenue for treating aortic dissection.
Supporting Evidence
- Elevated expression of ferroptosis markers was observed in aortic dissection patients.
- Silibinin treatment enhanced cell viability and mitochondrial function in human aortic smooth muscle cells.
- Silibinin administration reduced aortic dilation and inflammation in mouse models.
- RNA-sequencing analysis identified dysregulation of iron homeostasis and endoplasmic reticulum stress modulated by silibinin.
Takeaway
Silibinin is a natural compound that helps protect heart cells from a dangerous type of cell death called ferroptosis, which can happen during a serious heart condition called aortic dissection.
Methodology
The study involved in vivo experiments on mice and in vitro experiments on human aortic smooth muscle cells, assessing the effects of silibinin on ferroptosis markers and cell viability.
Limitations
The study primarily focused on mouse models and human aortic tissue, which may not fully represent the complexity of aortic dissection in all patients.
Participant Demographics
Human aortic samples were obtained from patients undergoing open surgical repair.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website